Chih-Hung Hsu

8PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 21, 2026
Neoadjuvant immunochemoradiotherapy with nivolumab, paclitaxel, and cisplatin followed by esophagectomy for locally advanced esophageal squamous cell carcinoma.

Ta-Chen Huang, Jhe-Cyuan Guo, Chia-Chi Lin

|Dec 10, 2025
Expression of Poliovirus Receptor, the Ligand of TIGIT, Associated With Immune-Cold Tumor Microenvironment in Hepatocellular Carcinoma.

Li-Chun Lu, Yi-Hsuan Lee, Yu-Yun Shao

|Nov 10, 2025
Does chemotherapy regimen matter for first-line immunochemotherapy in low PD-L1-expressing esophageal squamous cell carcinoma? A systemic review and meta-analysis.

Jhe-Cyuan Guo, Pei-Shan Lin, Wen-Yi Shau

|Apr 03, 2025
NOTCH1 Mutation and Survival Analysis of Tislelizumab in Advanced or Metastatic Esophageal Squamous Cell Carcinoma: A Biomarker Analysis From the Randomized, Phase III, RATIONALE-302 Trial.

Zhihao Lu, Wenting Du, Xi Jiao

|Aug 28, 2024
Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab.

Ying-Chun Shen, Tsung-Hao Liu, Alan Nicholas

|Jun 21, 2023
Different immune contextures underlie tumor site-specific responses to immune checkpoint blockade in esophageal cancer.

Jhe-Cyuan Guo, Chia-Lang Hsu, Min-Shu Hsieh

Pageof 2

Frequent Collaborators

4 joint publications

Jhe-Cyuan Guo

2 joint publications

Tsung-Hao Liu

2 joint publications

Ann-Lii Cheng

2 joint publications

Li-Chun Lu